Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-3
pubmed:dateCreated
2002-7-9
pubmed:abstractText
Topiramate, a novel anticonvulsant, has shown promise in preliminary open trials in bipolar disorder, but there are no studies in primary depression. Topiramate's tendency to cause weight loss could be advantageous for many patients with mood disorders.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0165-0327
pubmed:author
pubmed:issnType
Print
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
251-5
pubmed:dateRevised
2009-9-28
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Do obese depressed patients respond to topiramate? A retrospective chart review.
pubmed:affiliation
Mood Disorders Program, Butler Hospital and Department of Psychiatry and Human Behavior, Brown University School of Medicine, 345 Blackstone Blvd., Providence, RI 02906, USA. linda_carpenter_md@brown.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't